BILCARE LTD.-$

Bilcare Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. All designated persons are prohibited from trading during this period. The date of the board meeting to approve these financial results will be communicated separately.

Bilcare Limited has received an order from the National Company Law Tribunal (NCLT), Mumbai Bench, regarding the repayment of fixed deposits. The NCLT has condoned the delay in repayment, directed the company to deposit the outstanding amount with accrued interest into the IEPF Deposit Account by July 15, 2026, and to publish notices to unpaid depositors. The company has already repaid ₹168.76 crores and is awaiting details from remaining deposit holders for the balance ₹2.52 crores. Bilcare is taking steps to comply with the NCLT's directions.

Bilcare Limited has decided not to exercise its option to convert 3,15,000 warrants in Caprihans India Limited. This decision, approved by the Board via circular resolution on June 4, 2026, was based on liquidity, capital allocation, and business needs. Consequently, the ₹1.57 crore upfront subscription amount paid for these warrants will be forfeited as they lapse on June 4, 2026. Bilcare will comply with applicable disclosure requirements.

Bilcare Limited's Board of Directors approved the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. The board did not recommend any dividend for the year. The company redeemed 1,56,00,000 preference shares of Caprihans India Limited and converted 10,40,000 warrants into equity shares of Caprihans India Limited. The Board Meeting commenced at 15:30 (IST) and concluded at 23:55 (IST).

Bilcare Limited's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board did not recommend any dividend for the year. The company redeemed 1,56,00,000 Preference Shares of Caprihans India Limited. Additionally, 10,40,000 warrants were converted into equity shares of Caprihans India Limited, altering Bilcare's shareholding in the company.

Bilcare Limited announced the redemption of 1,56,00,000 preference shares of Caprihans India Limited (CIL) and the conversion of 10,40,000 warrants into equity shares of CIL. The company redeemed 78,00,000 shares on May 28, 2026, and 78,00,000 shares on May 29, 2026. Post-conversion, Bilcare's shareholding in CIL increased, reaching 105,18,325 equity shares, representing 62.04% of the total equity share capital. The Board of Directors approved the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026, with no dividend recommended.

Bilcare Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026. The trading window has been closed from April 1, 2026, until 48 hours after the declaration of the results, as per SEBI regulations.

Bilcare Ltd. has announced the redemption of 31,50,000 Preference Shares of Caprihans India Limited, worth approximately INR 3.15 crore. Additionally, the company has converted 12,90,000 warrants into equity shares of Caprihans India Limited. Furthermore, Bilcare's wholly owned subsidiary in the United Kingdom, Bilcare GCS Limited, has successfully completed its voluntary liquidation. The liquidation proceedings have resulted in a remittance of GBP 195,781.83 to the company.

Bilcare Ltd. has announced the redemption of 31,50,000 Preference Shares of Caprihans India Limited and the conversion of 12,90,000 Warrants into Equity Shares. The company has also updated on the successful completion of the voluntary liquidation of its wholly owned subsidiary, Bilcare GCS Limited, in the United Kingdom.

Bilcare Limited has informed the Exchange about the update on Voluntary Liquidation of its Wholly Owned Subsidiary, Bilcare GCS Limited, in the United Kingdom. The company has successfully completed the voluntary winding up of the subsidiary as per the applicable laws of England & Wales. In addition, Bilcare Limited has redeemed 31,50,000 (Thirty-one Lakh Fifty Thousand) 0.1% Non-Cumulative, Non-Participating Redeemable Preference Shares of Caprihans India Limited, and converted 12,90,000 (One Lakh Twenty-Nine Thousand) warrants into equity shares of Caprihans India Limited.